Results 281 to 290 of about 84,601 (303)

B lymphocytes contribute to stromal reaction in pancreatic ductal adenocarcinoma

OncoImmunology, 2020
Marco Lanzillotta, Lucrezia Rovati, Takashi Maehara   +2 more
exaly  

The Activated Stroma Index Is a Novel and Independent Prognostic Marker in Pancreatic Ductal Adenocarcinoma

Clinical Gastroenterology and Hepatology, 2008
Mert Erkan, Christoph W Michalski, Simon Rieder   +2 more
exaly  

Pancreatic Ductal Adenocarcinoma

2023
Anushri Parakh, Yoshifumi Noda, Avinash R. Kambadakone, Dushant V. Sahani   +3 more
openaire   +1 more source

Therapeutic trends in pancreatic ductal adenocarcinoma (PDAC)

Expert Opinion on Investigational Drugs, 2019
Hani M Babiker, Daruka Mahadevan
exaly  

HMGA1 correlates with advanced tumor grade and decreased survival in pancreatic ductal adenocarcinoma

Modern Pathology, 2009
Alexandra C Hristov, Francescopaolo Di Cello, Mansher Singh   +2 more
exaly  

BTN3A is a prognosis marker and a promising target for Vγ9Vδ2 T cells based-immunotherapy in pancreatic ductal adenocarcinoma (PDAC)

OncoImmunology, 2018
Celine Loncle, Mauro Modesti, Véronique Secq   +2 more
exaly  

Myeloid-derived macrophages and secreted HSP90α induce pancreatic ductal adenocarcinoma development

OncoImmunology, 2018
Chia-Chi Chen, Chung-Pin Li, Shih Sheng Jiang   +2 more
exaly  

Pancreatic ductal adenocarcinoma immune microenvironment and immunotherapy prospects

Chronic Diseases and Translational Medicine, 2020
Keyu Li, Nan Niu, Chun-Hui Yuan
exaly  

GADD45α is highly expressed in pancreatic ductal adenocarcinoma cells and required for tumor cell viability

International Journal of Cancer, 2006
Gunter Schneider, Franz Oswald, Roland M Schmid   +2 more
exaly  

Epithelial to mesenchymal plasticity and differential response to therapies in pancreatic ductal adenocarcinoma

Proceedings of the National Academy of Sciences of the United States of America, 2019
Vishal Thapar, Annamaria Szabolcs, Azfar Neyaz   +2 more
exaly